$MLHC news M Line Holdings, Inc. Highlights Fiscal 2014

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz Jack30 #24406
$MLHC news

M Line Holdings, Inc. Highlights Fiscal 2014 Achievements to Date
Management Sharpens Its Corporate Focus to Further Capture Aerospace Demand and Increase Shareholder Value

TUSTIN, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- M Line Holdings, Inc. (OTCQB:MLHC) ("M Line" or the "Company" , is a leading provider of products, assemblies and services to the precision high tech segment of both the aerospace and medical industries as well as selling high end pre-owned Japanese Computer Numerically Controlled ("CNC" Machine Tool Equipment, with key customers that include Panasonic Avionics, UTC Aerospace Systems, Beckman Coulter, BE Aerospace, and a strategic alliance with Structural Integrity Engineering, today provided highlights of its Fiscal 2014 achievements.

Fiscal 2014 has been an excellent year so far. The majority of our key achievements have been previously noted in our press releases and can be summarized as follows:

Restored Profitability-3 quarters in a row
Through March 31, 2014 we are approximately $1.8 million ahead of the comparable period for last year.

Obtained a Commitment for Acquisition Financing
Despite our weak financial condition and tight cash flow we obtained a commitment in the sum of $30 million.

Improved and Strengthened Management
We added Bruce Barren to our management team as CEO and brought in our first totally independent Board Member, Percy Cerff.

Rejuvenated Old and Attracted New Customers
We have added five new customers and rejuvenated 4 old customers.

Accelerated Discussions with Three Prospective Acquisitions
These first three prospective acquisitions represent over $15 million of new revenue and $3 million of EBITDA.

Completed a Strategic Alliance to Expand Products and Services to the Aerospace Industry
This co-operation agreement with Structural Integrity Engineering, Inc., an aerospace based engineering company, will enhance both company's abilities and strengths to service the aerospace industry.

Expanded Production Capacity in our machine refurbishing and sale division
Increased the machine refurbishing and sales division's facility size by over 50% to meet growing demand.

With everything that has been done we are not satisfied and continue to look for more acquisition prospects while searching for better ways to manage M Line, reducing overheads and improving productivity.

Bruce Barren, CEO of M Line, commented, "These accomplishments are just the beginning. We plan to do more to improve our profitability and enhance shareholder value which, as we have stated so many times, remains our primary objective. For anyone who remains skeptical, keep watching for we are full committed to our mission."

Tony Anish, COO of M Line, added, "While achieving so much in such a short time, we are definitely not complacent. In fact we are consistently striving for better results. We will not be satisfied until the market's view of our Company begins reflecting its true value."

The Company has set in motion plans to hold regular shareholder conference calls, which are expected to start in June. Management encourages all shareholders and prospective shareholders utilize this platform to ask questions to and talk with their team. More information will be sent out shortly.

For more information on M Line see our website at http://www.mlineholdings.com/

Safe Harbor and Informational Statement

This press release may contain forward-looking information within the meaning of Section 21E of the Security Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial conditions or results of operations; (iii): the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends.

The words "may", "would", "will", "expect", "estimate", "anticipate", "believe", "intend", and similar expressions and variations thereof are intend to identify forward-looking statements. Investors are cautioned that any such forward-looking statement are not a guarantee of future of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's statements and reports filed with the OTC Markets. The Company claims the safe harbor provided by Section 21E(c) of the Exchange Act for all forward-looking statements.

CONTACT: Investor Relations: Howard Gostrand info@amcapventures.com 305.918.7000


Source: GlobeNewswire (May 13, 2014 - 8:35 AM EDT)

News by QuoteMedia
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding KKR's Position Amidst Market Dynamics

Updated Category News Views 272

KKR Market Performance and Short Interest Trends KKR has recently witnessed a rise in its short percent of float, hitting 9.33% since the last report. The company disclosed approximately 11.08 million shares sold short, indicating that roughly 1.64% of its regular shares available for trading are currently shorted. Based on recent trading activities, analysts suggest it...

Continue Reading
Wilson & Company Welcomes Rajan Sheth to Board of Directors

Updated Category News Views 188

Wilson & Company Welcomes Rajan Sheth to Board of Directors Wilson & Company, Inc., Engineers & Architects has exciting news to share: the appointment of Rajan Sheth to its esteemed Board of Directors. Sheth's extensive experience in the consulting engineering and architecture realms gives him a unique edge as he steps into this crucial role. His three-year term is...

Continue Reading
Exciting Updates on Kalmar Corporation's Recent Transactions

Updated Category News Views 153

Latest Managers' Transactions at Kalmar Corporation Kalmar Corporation has made headlines recently regarding the transactions carried out by its management. Recognized for its significant contributions in material handling, the company remains at the forefront of innovative supply chain solutions. Transaction Overview Sari Pohjonen, a member of the board and deputy member...

Continue Reading
European Markets Respond to Earnings Amid Growth Concerns

Updated Category News Views 74

European Stock Markets Experience Stagnation European stock markets faced a stagnant session recently, with investors closely monitoring a wave of corporate earnings reports. Amid uncertainty regarding regional growth, market participants seemed to take a cautious stance. Deutsche Bank's Earnings Report In the spotlight was Deutsche Bank, which made headlines as it...

Continue Reading
Understanding the Class Action Against ASP Isotopes Inc.

Updated Category News Views 441

Insights into the Class Action Lawsuit against ASP Isotopes Inc. Pomerantz LLP has recently made headlines by filing a class action lawsuit against ASP Isotopes Inc. (NASDAQ: ASPI), bringing attention to potential issues surrounding the company's business practices. The class action aims to address allegations of securities fraud that could have impacted shareholders'...

Continue Reading